Lifeward CEO receives 172,698 stock options

Lifeward Ltd. President and CEO Grant William Mark received a grant of stock options covering 172,698 ordinary shares.

Rhea-AI Filing Summary

Lifeward Ltd. President and CEO Grant William Mark received a grant of stock options covering 172,698 ordinary shares. The options have an exercise price of $6.53 per share and expire on March 25, 2036.

The award vests over four years, with 25% of the underlying shares vesting on March 25, 2027. The remaining 75% vests in equal monthly installments over the following 36 months, contingent on his continued service, with potential acceleration under the applicable plan and grant terms.

Insider Trade Summary

Grant/Award: 172,698 shares

Grant/Award 1 txn

Insider Grant William Mark

Role President & CEO

Type	Security	Shares	Price	Value
Grant/Award	Option (Right to Buy)	172,698	$0.00	$0.00

Holdings After Transaction: Option (Right to Buy) — 172,698 contracts (Direct)

Footnotes (1)

1. F1. The shares underlying the option shall become vested and exercisable over four (4) years with 25% of the shares vesting on March 25, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, provided the reporting person's continued service with the Company on each applicable vesting date, subject to acceleration as provided in the applicable plan and non-qualified stock option grant. .

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Lifeward (LFWD) disclose about its CEO’s recent equity award?

Lifeward disclosed that President and CEO Grant William Mark received stock options for 172,698 ordinary shares. The options were granted at an exercise price of $6.53 per share and are structured as a long-term incentive equity award.

How many stock options were granted to Lifeward CEO Grant William Mark?

Grant William Mark was granted options covering 172,698 ordinary shares. These options give him the right to buy shares at a fixed exercise price of $6.53 per share, subject to vesting and other conditions in the award documentation.

What is the vesting schedule for the Lifeward CEO’s new stock options?

The options vest over four years. Twenty-five percent of the underlying shares vest on March 25, 2027, with the remaining 75% vesting in equal monthly installments over the following 36 months, conditioned on his continued service with the company.

When do the newly granted Lifeward CEO options expire?

The stock options granted to Lifeward’s CEO expire on March 25, 2036. After that date, any unexercised portion of the award will no longer be exercisable, consistent with the long-term nature of this compensation grant.

At what price can the Lifeward CEO exercise his new stock options?

The options have an exercise price of $6.53 per ordinary share. This means the CEO can purchase shares at $6.53 per share once the options vest, subject to the specific terms of the plan and grant documents.

Are there conditions attached to the vesting of the Lifeward CEO’s options?

Yes. Vesting requires the CEO’s continued service with Lifeward on each applicable vesting date. The filing notes the award is also subject to potential vesting acceleration as provided in the applicable plan and non-qualified stock option grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 04:57 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grant William Mark

(Last) (First) (Middle)

C/O LIFEWARD LTD.

2 CABOT RD.

(Street)

HUDSON MASSACHUSETTS 01749

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	$6.53	03/25/2026		A		172,698		(1)	03/25/2036	Ordinary Shares, no par value per share	172,698	$0	172,698	D

Explanation of Responses:

1. The shares underlying the option shall become vested and exercisable over four (4) years with 25% of the shares vesting on March 25, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, provided the reporting person's continued service with the Company on each applicable vesting date, subject to acceleration as provided in the applicable plan and non-qualified stock option grant. .

	/s/ Almog Adar, as Attorney-in-Fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)